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1 
PINK SLIP INTRODUCTION 
DENA S. DAVIS1 
 
Is there a pink slip in your genes?  In this cleverly worded phrase, Paul Miller 
adroitly captures the fears of millions of Americans as we ponder whether the 
genetic revolution bodes us well or ill.  The Human Genome Project (HGP), which 
completed its first phase in 2000, succeeded in mapping the entire human genome, a 
breathtaking accomplishment.  Scientists promise that, in the future, genetic 
knowledge will enable us to fight cancer, treat hitherto intractable genetic diseases, 
create drugs perfectly calibrated to the needs of the individual recipient, come up 
with vaccines to fight new epidemics, and other wonders.  But meanwhile, while we 
await these promised miracles, the primary accomplishments of genetic research 
have been to identify, rather than to treat.  We can identify Tay-Sachs carriers, but 
we cannot treat Tay-Sachs.  We know that some women are at increased risk of 
breast and ovarian cancer because of their genetic make-up, but we can offer them 
little more than increased surveillance and prophylactic surgery.  We increasingly 
accept the notion that almost every health condition has a genetic component, but 
treatments and prophylaxis remain virtually unchanged. 
What has changed, however, is the degree of worry and concern that people feel 
about the uses to which their genetic information can be put.  When the HGP began, 
a number of pundits were convinced that the “future knowledge” that genetic 
information can deliver to consumers and insurers alike would completely 
undermine the practice of private health insurance, and send our current system 
crashing to the ground.  Needless to say, that has not happened; but with 42 million 
Americans currently without health insurance, and with insurance tightly entwined 
with employment, many people fear that genetic information will be used by 
employers and insurers to discriminate against those who appear to present higher 
risks. 
For most people, the HGP appears like an abstract and distant enterprise.  It is 
not, hard, however, to imagine scenarios that are anything but abstract and distant. 
My mother died of Huntington Disease.  Will any one want to hire me, 
knowing there is a fifty percent risk that I will have HD as well?  My 
spouse and I carry sickle cell trait.  Although we are healthy, we risk 
having children with sickle cell disease.  Can we get health insurance?  If 
we have jobs with insurance, can we afford to move, knowing that a new 
employer might not want to add potentially expensive employees to the 
group insurance pool?  My sister was just diagnosed with breast cancer.  
I’d like to have my own genetic risk analyzed, but I am afraid that, if the 
news is bad, my insurer will somehow get hold of it and cancel my 
coverage just when I need it most.  I’d like to take part in a new research 
project focusing on genetic diseases associated with my ethnic group 
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because I hope that in the long run it would benefit a lot of people, but I 
worry that my private information will get into the wrong hands. 
In the December 2001 conference at Cleveland-Marshall College of Law, titled Is 
There a Pink Slip in Your Genes? Genetic Discrimination in Employment and Health 
Insurance, we tried to grapple with these questions.  Thoughtful speakers addressed 
topics such as our current state of genetic knowledge; whether genetic discrimination 
exists; whether litigation, legislation, healthcare reform or some mixture of these 
approaches offers the best promise of combating discrimination; whether the 
Americans with Disabilities Act is a strong shield against such discrimination, and 
the very meaning of “disability” in this new age of genetic knowledge.  We are 
grateful to all who participated, and in this symposium issue of The Journal of Law 
and Health, we invite our readers to share the fruits of this endeavor.  
